| Literature DB >> 27611787 |
Gianguido Cossellu1, Valeria Motta2, Laura Dioni2, Laura Angelici2, Luisella Vigna3, Giampietro Farronato1, Angela Cecilia Pesatori2,3,4, Valentina Bollati2.
Abstract
OBJECTIVES: In this study on 90 individuals we aimed at evaluating the microRNAs (miRNAs) expression profile associated with personal levels of Titanium (Ti) and Zirconium (Zr) traced in hair samples. Ti and Zr materials are broadly used for dental implants but the biological reactions triggered by a long term presence of these materials in the oral cavity still need to be assessed. MiRNAs are mechanisms that need to be investigated as they play a fundamental role in the control of gene expression following external stimuli and contribute to a wide range of pathophysiological processes.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27611787 PMCID: PMC5017677 DOI: 10.1371/journal.pone.0161916
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Characteristics of the study participants and exposure levels (n = 90).
| Characteristics | |
|---|---|
| 51.6 ± 11.9 | |
| 15 (16.7%) | |
| 75 (83.3%) | |
| 32.9 ± 5.7 | |
| 34 (37.8%) | |
| 28 (31.1%) | |
| 19 (21.1%) | |
| 9 (10.0%) | |
| 48 (53.3%) | |
| 26 (28.9%) | |
| 16 (17.8%) | |
| 0.7 ± 0.4 | |
| 0.046 ± 0.06 | |
| 61.3 ± 7.6 |
List of miRNAs associated with Zirconium levels.
| microRNA | Exposure | %Variation | 95% CI | FDR | ||
|---|---|---|---|---|---|---|
| Zirconium | 58.83 | 106.32 | 22.27 | 0.001 | 0.027 | |
| Zirconium | 35.38 | 63.32 | 12.22 | 0.002 | 0.037 | |
| Zirconium | 40.69 | 74.84 | 13.2 | 0.003 | 0.053 | |
| Zirconium | 41.83 | 76.33 | 14.09 | 0.002 | 0.068 | |
| Zirconium | 35.32 | 65.32 | 10.76 | 0.004 | 0.07 | |
| Zirconium | 43.36 | 82.26 | 12.77 | 0.004 | 0.074 | |
| Zirconium | 50.37 | 95.02 | 15.94 | 0.003 | 0.098 | |
*FDR: False Discovery Rate
Percentage variation express the percentage change of miRNA expression associated with an increase of 1SD in Zirconium (%Variation = ((2^β)-1)*100 and 95% CIs).
Disease and biological function associated with target genes selected with IPA for 7 miRNAs.
| Categories | Diseases and Functions | # Targets | |
|---|---|---|---|
| Inflammation of organ | 5.17x10-20 | 111 | |
| Inflammation of body region | 4.25x10-19 | 97 | |
| Inflammation of body cavity | 1.06x10-18 | 79 | |
| Connective tissue inflammation | 8.41x10-17 | 88 | |
| Chronic inflammatory disorder | 8.63x10-17 | 84 | |
| Congenital anomaly of musculoskeletal system development | 2.21x10-23 | 69 | |
| Cellular development, growth and proliferation of skeletal tissue | 2.52x10-22 | 57 | |
| Congenital anomaly of skeletal bone | 8.34x10-21 | 48 | |
| Craniofacial abnormality | 5.34x10-20 | 44 | |
| Development and function of skeletal system | 1.49x10-17 | 45 | |
| Proliferation of fibroblast cell lines | 7.08x10-21 | 55 | |
| Congenital anomaly of skeletal bone | 8.34x10-21 | 48 | |
| Craniofacial abnormality | 5.34x10-20 | 44 | |
| Proliferation of fibroblasts | 5.66x10-17 | 46 | |
| Connective tissue development and function | 8.41x10-17 | 88 |
Fig 1Cellular location of targets shared by miR-152, miR-335 and miR-494.